Cargando…
IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
Autores principales: | Ruge, M., Sriram, U., Gomez, J.M.D., Du Fay De Lavallaz, J., Gajo, E., Sarau, A., Simmons, J.A., Volgman, A.S., Suboc, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164589/ http://dx.doi.org/10.1016/j.diabres.2022.109338 |
Ejemplares similares
-
PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022) -
ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022) -
BODY MASS INDEX, INFLAMMATION AND SEVERITY IN HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A CHICAGO AND MADRID RETROSPECTIVE COHORT STUDY
por: Park, Aaron, et al.
Publicado: (2023) -
The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients
por: Ruge, Max, et al.
Publicado: (2021) -
Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
por: Ruge, Max, et al.
Publicado: (2021)